MedTrace Logo

Somatic Stem Cells in Leiomyomas?

NCT01592903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2016-08-31

No results posted yet for this study

Summary

The purpose of this study is to identify and characterize the Somatic Stem Cell (SSC) responsible for the formation and growth of leiomyomas using the Side Population method.

Conditions

  • Leiomyomas

Interventions

GENETIC

Laparoscopic myomectomy. Following analysis and proliferation of cells isolated from removed human leiomyoma.

* Obtention of one part of removed human leiomyoma after surgery and maintained in 4ºC until procedures. * Sample digestion through controlled enzymes. * Isolated the "Side Population" from leiomyoma cell suspension by Flow cytometry . * Culture of these cells. * Morphological and genetic characterization. * Assessment of pluripotent potential from isolated cells. * Analysis of the degree of functionality.

Sponsors & Collaborators

  • Igenomix

    lead INDUSTRY

Principal Investigators

  • Carlos Simon, MDPhD · Igenomix

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01592903 on ClinicalTrials.gov